Home
Conditions
Neoplasms, Neuroepithelial

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,951 public trials 642 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Recruiting

Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study

NCT05904119

Conditions: Astrocytoma, First Progression of Glioblastoma, Glioblastoma, +8 more
Locations: A.O Landeskrankenhaus - Innsbruck Universitaetsklinik Innsbruck, Austria

Kepler University Hospital - Neuromed campus Linz, Austria

Universitaetsklinikum Wien - AKH unikliniken Vienna, Austria

AZORG Aalst, Belgium

View all 45 locations

View Trial Details

Recruiting

Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application

NCT06883214

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: "Regina Elena" National Cancer Institute Rome, Italy

View Trial Details

Recruiting

Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

NCT07450872

Conditions: Cancer, Disease, Glioma, +16 more
Locations: Children's Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

NCT07486713

Conditions: AML (Acute Myeloid Leukemia), Adenocarcinoma, Carcinoma, +15 more
Locations: UCI Irvine Health Orange, California, United States

New York Presbyterian Hospital-Columbia University Medical Center New York, United States

View Trial Details

Recruiting

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

NCT04547777

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Recruiting

Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children

NCT07318831

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +9 more
Locations: Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN

NCT07627334

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +8 more
Locations: AKH Vienna, Department for Internal Medicine I, Oncology Vienna, State of Vienna, Austria

View Trial Details

Recruiting

A Study of 177Lu-PSMA-617 in People With Gliomas

NCT07223034

Conditions: Astrocytoma, Diffuse Astrocytoma, IDH-Wildtype (Grade 2-4), Diffuse Hemispheric Glioma, H3 G34-Mutant, +12 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT06607692

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +57 more
Locations: HM Monteprincipe Boadilla del Monte, Madrid, Spain

View Trial Details

Recruiting

Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients

NCT03546387

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +12 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Neoplasms, Neuroepithelial

Neoplasms, Neuroepithelial trial results

Related conditions